Uric acid (UA), traditionally associated with gout, is now gaining prominence as a potential target in neurodegenerative diseases
It is composed of three amino acids: cysteine, glycine, and glutamic acid
[14] ( Figure 1A ) Approved in 2023, tirzepatide (TZP) is a dual GIP/GLP-1 receptor agonist that significantly enhances glycemic control and is under clinical investigation for obesity, cardiovascular disease, and non-alcoholic steatohepatitis
When combined with the other ingredients in Lipo-C, Choline influences fat burning to boost a weight loss plan that includes diet and exercise
These characteristics make it a good support to reduce triglycerides and increase good cholesterol ( HDL)
Overall, liraglutide serves as both a GLP-1 receptor agonist and a sustained-release microsphere formulation, demonstrating its potential for long-term T2DM management